INSIDER · CIK 1943192
Cline Christopher R.
CHIEF FINANCIAL OFFICER at Travere Therapeutics, Inc. (TVTX)
↗3 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$3.2MSold on the market
1Companies
Sep 17, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 17, 202621:30 | Sep 15, 2026 | TVTXTravere Therapeutics, Inc. | CHIEF FINANCIAL OFFICER | S · Sell10b5-1 | $62.34 | −50,508 | 87,508 | -37% | −$3.1M | ||
| Sep 17, 202621:30 | Sep 15, 2026 | TVTXTravere Therapeutics, Inc. | CHIEF FINANCIAL OFFICER | M · Exercise10b5-1 | $17.44 | +20,000 | 138,016 | +17% | $349K | ||
| Sep 3, 202616:05 | Sep 2, 2026 | TVTXTravere Therapeutics, Inc. | CHIEF FINANCIAL OFFICER | S · Sell | $66.37 | −642 | 118,016 | -1% | −$43K |